___

⚡️🇪🇺#отчетности #европа AstraZeneca Q2 Earnings: -Revenue: $6.28B (est $6.28B) -Core EPS: 96C (est 93C) -Farxiga Rev: $443M (est $436.6M) -Tagrisso Rev: $1.03B (est $1.02B) -Interim Div/Share: 90C -Retains FY Guidance